We are live on ! Find out more
BSX icon

Boston Scientific

556 hedge funds and large institutions have $27.2B invested in Boston Scientific in 2016 Q4 according to their latest regulatory filings, with 75 funds opening new positions, 184 increasing their positions, 223 reducing their positions, and 75 closing their positions.

New
Increased
Maintained
Reduced
Closed

36% more call options, than puts

Call options by funds: $78.3M | Put options by funds: $57.4M

0.49% more ownership

Funds ownership: 91.82%92.31% (+0.49%)

0% more first-time investments, than exits

New positions opened: 75 | Existing positions closed: 75

2% less funds holding

Funds holding: 565556 (-9)

7% less capital invested

Capital invested by funds: $29.4B → $27.2B (-$2.18B)

17% less repeat investments, than reductions

Existing positions increased: 184 | Existing positions reduced: 223

44% less funds holding in top 10

Funds holding in top 10: 169 (-7)

Holders
556
Holders Change
-9
Holders Change %
-1.59%
% of All Funds
13.9%
Holding in Top 10
9
Holding in Top 10 Change
-7
Holding in Top 10 Change %
-43.75%
% of All Funds
0.23%
New
75
Increased
184
Reduced
223
Closed
75
Calls
$78.3M
Puts
$57.4M
Net Calls
+$20.9M
Net Calls Change
-$14.7M
Name Holding Trade Value Shares
Change
Change in
Stake
AIM
326
Assured Investment Management
New York
$1.04M -$1.33M -60,991 -56%
SG
327
Somerset Group
Minnesota
$1.04M
Natixis Advisors
328
Natixis Advisors
Massachusetts
$1.04M -$246K -11,297 -19%
Thrivent Financial for Lutherans
329
Thrivent Financial for Lutherans
Minnesota
$1.03M -$1.33M -61,130 -56%
TI
330
Trexquant Investment
Connecticut
$1.02M -$1.2M -55,200 -54%
GCA
331
Greenwood Capital Associates
South Carolina
$1.02M -$35.3K -1,620 -3%
GGHC
332
Gilder Gagnon Howe & Co
New York
$1.02M +$349 +16 +0%
Wolverine Trading
333
Wolverine Trading
Illinois
$995K -$350K -16,022 -26%
EEG
334
E.E. Geduld
$976K
B
335
Barings
North Carolina
$963K -$543K -24,900 -36%
KRSITF
336
Kentucky Retirement Systems Insurance Trust Fund
Kentucky
$954K +$1.11K +51 +0.1%
MERSOM
337
Municipal Employees' Retirement System of Michigan
Michigan
$950K +$16.4K +750 +2%
FIM
338
Fernwood Investment Management
Massachusetts
$947K -$21.8K -1,000 -2%
FQ
339
First Quadrant
California
$921K
SAM
340
Sunnymeath Asset Management
New Jersey
$905K +$87.3K +4,000 +11%
BFO
341
Boston Family Office
Massachusetts
$900K +$160K +7,325 +21%
VIA
342
Virtus Investment Advisers
Connecticut
$898K -$872K -39,970 -49%
Creative Planning
343
Creative Planning
Kansas
$888K +$7.42K +340 +0.8%
VKH
344
Virtu KCG Holdings
New York
$878K -$344K -15,753 -28%
FRM
345
Fox Run Management
Connecticut
$870K +$877K +40,200 New
NSEDCP
346
NJ State Employees Deferred Compensation Plan
New Jersey
$865K
William Blair & Company
347
William Blair & Company
Illinois
$837K -$15.8K -723 -2%
RJFSA
348
Raymond James Financial Services Advisors
Florida
$836K -$219K -10,049 -21%
LTFS
349
Ladenburg Thalmann Financial Services
Florida
$834K -$79.1K -3,623 -9%
GT
350
Glenmede Trust
Pennsylvania
$826K -$2.05K -94 -0.2%

BSX Hedge Fund Activity: Q4 2016 in Review

556 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q4 2016, worth a combined $27.2B — down 7.4% from $29.4B a quarter earlier.

Fund positioning in BSX was balanced in Q4 2016: 75 funds opened new positions, 75 closed out, 184 added to existing stakes and 223 trimmed.

The largest buyer was Janus Henderson Investors US, adding an estimated $137M. The largest seller was Wellington Management Group, cutting an estimated $151M.

  • 556 institutional investors held Boston Scientific (BSX) as of Q4 2016, down from 565 in Q3 2016.
  • Funds reported $27.2B of Boston Scientific stock for Q4 2016, down 7.4% quarter-over-quarter.
  • 75 funds opened new Boston Scientific positions in Q4 2016 and 75 closed out, a net change of 0 holders.
  • The largest Boston Scientific buyer in Q4 2016 was Janus Henderson Investors US, an estimated $137M added.
  • The largest Boston Scientific seller in Q4 2016 was Wellington Management Group, an estimated $151M sold.

Based on aggregated 13F filings for Q4 2016.